Haematologic impact of [177Lu]Lu-PSMA-617 versus ARPI change in patients with metastatic castration-resistant prostate cancer in PSMAfore Meeting Abstract


Authors: Chi, K. N.; Sartor, O.; Fizazi, K.; de Bono, J. S.; Shore, N. D.; Herrmann, K.; Castellano Gauna, D. E.; Piulats Rodriguez, J. M.; Flechon, A.; Wei, X. X.; Kim, H.; Schweizer, M.; Alanee, S.; Ghebremariam, S.; Hertelendi, M.; Morris, M. J.
Abstract Title: Haematologic impact of [177Lu]Lu-PSMA-617 versus ARPI change in patients with metastatic castration-resistant prostate cancer in PSMAfore
Meeting Title: ESMO Congress 2024
Journal Title: Annals of Oncology
Volume: 35
Issue: Suppl. 2
Meeting Dates: 2024 Sep 13-17
Meeting Location: Barcelona, Spain
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2024-09-01
Start Page: S972
End Page: S973
Language: English
ACCESSION: WOS:001326612902233
DOI: 10.1016/j.annonc.2024.08.1692
PROVIDER: wos
Notes: Meeting Abstract: 1611P -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Michael Morris
    577 Morris